Jun Wang

Jun Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXin Zhou
Xin Zhou
YGYanling Guo
Yanling Guo
KYKun Yang
Kun Yang
PLPeng Liu
Peng Liu
JWJun Wang
Jun Wang

1 May 2021 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
QLQingwei Lu
Qingwei Lu
JWJun Wang
Jun Wang
XWXiaolu Wei
Xiaolu Wei
GWGang Wang
Gang Wang
YXYang Xu
Yang Xu
Abstarct: Background: The purpose of our study was to identify the new and the more specific risk factors for major amputation in patients with diabetic foot ulcer (DFU). Methods: We used data from the Electronic Medical Record (EMR) database of our hospital from February 2014 to July 2020. Patients with DFU and amputation were included in the study. The logistic regression model was adjusted for demographic characteristics and related comorbidities between major and minor amputation groups. Results: Among 3654 patients with DFU, 363 (9.9%) were amputated. Patients with major versus minor amputation, in multivariable logistic regression models, major amputation independent factors included previous amputation history (odds ratio [OR] 2.31 [95% CI 1.17– 4.53], p = 0.02), smoking (2.58 [1.31– 5.07], p = 0.01), coronary artery disease (CAD) (2.67 [1.35– 5.29], p = 0.03), ankle brachial index (ABI) < 0.4 (15.77 [7.51– 33.13], p < 0.01), Wagner 5 (5.50 [1.89– 16.01], p < 0.01), activated partial thromboplastin time (APTT) (1.23 [1.03– 1.48], p = 0.01), glycosylated hemoglobin A1c (HbA1c) (1.23 [1.03– 1.48], p = 0.03), hemoglobin (Hb) (0.98 [0.96– 1.00], p = 0.01), plasma albumin (ALB) (0.88 [0.81– 0.95], p < 0.01) and white blood cell (WBC) (1.10 [1.04– 1.16], p < 0.01). Conclusion: Major amputation was associated with previous amputation history, smoking, CAD, Wagner 5, ABI < 0.4, HbA1c, Hb, ALB, WBC, and APTT might be a new independent factor. In view of these factors, early prevention and guidance promptly orientated by multidisciplinary is of great significance to reduce the disability rate and economic burden.

1 November 2020 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
QLQingwei Lu
Qingwei Lu
JWJun Wang
Jun Wang
XWXiaolu Wei
Xiaolu Wei
GWGang Wang
Gang Wang
YXYang Xu
Yang Xu
PLPeng Liu
Peng Liu
Background: The cost of care for diabetic foot ulcers has became a global economic burden. The study aimed to analyze diabetic foot ulcer cost changes over time and to identify factors associated with these variables, so as to strengthen and improve the management of diabetic foot ulcers. Methods: We retrospectively analyzed the data in the electronic medical record system of our wound treatment center. The homepage of the system was queried using the national clinical version 2.0 disease diagnosis code (ICD-10), the data of patient’s basic information were exported. Through the statistics and analysis of these data, the socioeconomic changes and possible risk factors of diabetic foot ulcers management in recent years were obtained. Results: There were 3654 patients included in the study, an average of 522 per year. The total cost per patient increased from ¥ 15,535.58 in 2014 to ¥ 42,040.60 in 2020, with an average of ¥ 21,826.91. The average length of stay between 14.29 days and 31.4 days from 2014 to 2020, with an average of 18.10 days. Besides, the average incidence of peripheral arterial disease in diabetic foot ulcers patients admitted was as high as 81.9%, and the average amputation rate was 9.9%. The study reflected the total cost and length of stay of diabetic foot patients increased significantly from 2014 to 2020, which were related to age (> 85 years), gender (male), peripheral arterial disease, amputation (P < 0.05). Conclusion: A heavy cost from diabetic foot ulcers and its complications was significantly increased yearly, which was related to older age, co-morbidity, amputation and duration of hospitalization. The prevention and treatment of diabetic foot ulcers have a long way to go, early comprehensive prevention and multi-disciplinary cooperation may still be an effective way.

15 November 2025 in World Journal of Diabetes
Verified
Journal Article
Open access
YGYan-Ling Guo
Yan-Ling Guo
WNWen-Jing Niu
Wen-Jing Niu
HJHao-Ran Jiao
Hao-Ran Jiao
YLYun-Ping Li
Yun-Ping Li
CXChuan Xu
Chuan Xu
JWJun Wang
Jun Wang
Oxidative stress and inflammation are closely interrelated processes that are pivotal to the impaired wound healing associated with diabetes. Chronic hyperglycemia in diabetic patients induces excessive reactive oxygen species (ROS) production, which triggers heightened inflammatory responses. The resulting inflammation exacerbates oxidative damage, delays wound closure, and intensifies tissue injury, thereby creating a detrimental cycle that disrupts normal wound healing. Recent research has increasingly focused on the therapeutic potential of natural products in modulating oxidative stress and inflammation to enhance diabetic wound healing. Natural compounds, such as polyphenols, flavonoids, and terpenoids, have demonstrated significant efficacy in reducing oxidative damage and modulating inflammatory pathways. These bioactive agents exhibit potent antioxidant activity by scavenging ROS and enhancing endogenous antioxidant defenses while concurrently inhibiting the release of proinflammatory cytokines. Additionally, natural therapies have been shown to promote angiogenesis, enhance collagen synthesis, and improve fibroblast function, further facilitating wound repair. This review provides insights into the complex interplay between oxidative stress and inflammation in diabetic wound healing and evaluates the therapeutic potential of natural products as adjunctive treatments. Further clinical investigations are essential to validate the efficacy and safety of these natural interventions for diabetic wound management.

15 November 2024 in World Journal of Diabetes
Verified
Journal Article
Open access
XZXin Zhou
Xin Zhou
YGYan-Ling Guo
Yan-Ling Guo
CXChuan Xu
Chuan Xu
JWJun Wang
Jun Wang
In this editorial, we discuss the article by Wen et al published. Diabetic foot ulcers are prevalent and serious complications of diabetes, significantly impacting patients’ quality of life and often leading to disability or death, thereby placing a heavy burden on society. Effective diabetic wound healing is hindered by an imbalance in macrophage polarization; many macrophages fail to transition from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, which is crucial for tissue remodelling and repair. The wound healing process is both dynamic and complex. Healthy M1 macrophages, which have strong phagocytic abilities, are vital during the inflammatory phase of diabetic wound healing. However, the failure to transition to M2 macrophages during the proliferative phase hinders wound healing. We anticipate the development of new therapies that can repair damaged M1 macrophages during the inflammatory phase and promote M2 macrophage polarization during the proliferative phase, thereby enhancing the overall healing process.